SynOx Therapeutics
Raymond Barlow is the Chief Executive Officer at SynOx Therapeutics, a biopharmaceutical company developing emactuzumab for the treatment of various disorders. Raymond is also the Founder of Ikigai Life Sciences, a consultancy business in the biopharmaceutical industry. With previous experience in companies like Kiadis Pharma, e-therapeutics PLC, and Amgen, Raymond has a strong background in corporate development and business leadership.
This person is not in any teams
This person is not in any offices
SynOx Therapeutics
SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is backed by a strong investor syndicate with long and successful backgrounds in building biopharma companies.